Susi Roger E.'s Form 4 filing
Iradimed Corp (IRMD) · filed Apr 7, 2026
- Accession no.
- 0001613801-26-000022
- Filed
- Apr 7, 2026
- Trade date
- Apr 6-7, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions. Open-market sales total $717.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Susi Roger E.CIK 0001613801 | Director, Officer (CEO, President, Chairman), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Common Stock | SSaleDisposed | −1,357 | $95.21F2 | −$129,199.97 | 2,223,643 | Indirect | |
| Apr 6, 2026 | Common Stock | SSaleDisposed | −3,074 | $96.24F3 | −$295,841.76 | 2,220,569 | Indirect | |
| Apr 6, 2026 | Common Stock | SSaleDisposed | −569 | $96.78F4 | −$55,067.82 | 2,220,000 | Indirect | |
| Apr 7, 2026 | Common Stock | SSaleDisposed | −1,518 | $94.36F5 | −$143,238.48 | 2,218,482 | Indirect | |
| Apr 7, 2026 | Common Stock | SSaleDisposed | −982 | $95.58F6 | −$93,859.56 | 2,217,500 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $94.54 to $95.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $95.61 to $96.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $96.61 to $97.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $94.15 to $95.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $95.17 to $95.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.